The FDA granted breakthrough device status to Prescient Metabiomics' Lifekit Prevent colorectal neoplasia test. Prescient Metabiomics is a subsidiary of Carlsbad, Calif.-based Prescient Medicine Holdings Inc.
Evaxion Biotech A/S is leveraging two artificial intelligence (AI) platforms to quickly identify targets for cancer immunotherapies and infectious diseases.
Researchers from the Swiss École Polytechnique Fédérale de Lausanne (EPFL) and the University Medical Center Utrecht in the Netherlands have developed a bioprinting process that allows simultaneous production of the entire volume of complex shapes, providing much greater flexibility and faster production than layer-by-layer 3D printing. Details on the process, called volumetric printing, and printer were published in Advanced Materials.
Dublin-based Medtronic plc reported the retirement of CEO Omar Ishrak effective April 26, 2020. In a move that may lead to further changes at the company, the board named Geoff Martha, currently executive vice president of Medtronic's restorative therapies group, Ishrak's successor. Martha edged out the previous frontrunner for the job, Mike Coyle, who heads Medtronic's cardiac and vascular group, the company's largest division.
A head-to-head-to-head trial comparing three top-selling drug-eluting stents (DES) over three years found no statistically significant differences between them in terms of revascularization rates or stent thrombosis, according to a study published in the Journal of the American Medical Association.